Update on diagnosis and management of neoplastic pericardial disease

被引:9
作者
Avondo, Stefano [1 ]
Andreis, Alessandro [1 ]
Casula, Matteo [1 ]
Imazio, Massimo [1 ]
机构
[1] AOU Citta Salute & Sci Torino, Cardiovasc & Thorac Dept, Univ Cardiol, Turin, Italy
关键词
Pericardium; mass; tumor; neoplastic; effusion; ENDOTHELIAL GROWTH-FACTOR; MALIGNANT MESOTHELIOMA; EUROPEAN ASSOCIATION; PLEURAL EFFUSION; CARDIAC TUMORS; RADIOTHERAPY; PHARMACOKINETICS; CHEMOTHERAPY; BIOMARKERS; CYFRA-21-1;
D O I
10.1080/14779072.2020.1811087
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction: Pericardial neoplasms are uncommon, mostly due to secondary involvement of the pericardium by extracardiac tumors. Clinical presentation is nonspecific, frequently leading to a delayed diagnosis. Moreover, both benign and malignant pericardial tumors may be associated with myocardial infiltration and mechanical compression of cardiac chambers, possibly precipitating clinical conditions. Pericardial tumors are indeed a diagnostic and therapeutic clinical challenge. Areas covered: This review aims to provide an overview of the main clinical characteristics of pericardial tumors, along with their management in clinical practice. Expert commentary: Multimodality imaging (echocardiography, chest X-ray, CT, CMR, and PET) enable full characterization of pericardial neoplasms. An individualized strategy should be developed by a multidisciplinary team including cardiologists, oncologists, radiologists, and cardiac surgeons.
引用
收藏
页码:615 / 623
页数:9
相关论文
共 73 条
[51]   Long-Term Outcomes after Video-Assisted Thoracoscopic Pericardiectomy for Pericardial Effusion [J].
Mizukami, Yasushi ;
Ueda, Nobuhito ;
Adachi, Hirofumi ;
Arikura, Jun ;
Kondo, Keishi .
ANNALS OF THORACIC AND CARDIOVASCULAR SURGERY, 2017, 23 (06) :304-308
[52]   Toxicities of the anti-PD-1 and anti-PD-L1 immune checkpoint antibodies [J].
Naidoo, J. ;
Page, D. B. ;
Li, B. T. ;
Connell, L. C. ;
Schindler, K. ;
Lacouture, M. E. ;
Postow, M. A. ;
Wolchok, J. D. .
ANNALS OF ONCOLOGY, 2015, 26 (12) :2375-2391
[53]  
Nishino M, 2011, NEW ENGL J MED, V43
[54]   Diagnostic value of CYFRA 21-1 turner marker end CEA in pleural effusion due to mesothelioma [J].
Paganuzzi, M ;
Onetto, M ;
Marroni, P ;
Filiberti, R ;
Tassara, E ;
Parodi, S ;
Felletti, R .
CHEST, 2001, 119 (04) :1138-1142
[55]   Pathological study of primary cardiac and pericardial tumours in a specialist UK Centre: surgical and autopsy series [J].
Patel, Junaid ;
Sheppard, Mary N. .
CARDIOVASCULAR PATHOLOGY, 2010, 19 (06) :343-352
[56]  
Petrella F, 2018, SHANGHAI CHEST, V2, P45
[57]  
POHJOLASINTONEN S, 1987, CANCER-AM CANCER SOC, V60, P31, DOI 10.1002/1097-0142(19870701)60:1<31::AID-CNCR2820600107>3.0.CO
[58]  
2-D
[59]   Concurrent cisplatin/etoposide plus 3D-conformal radiotherapy followed by surgery for stage IIB (superior sulcus T3N0)/III non-small cell lung cancer yields a high rate of pathological complete response [J].
Pourel, Nicolas ;
Santelmo, Nicola ;
Naafa, Nidal ;
Serre, Antoine ;
Hilgers, Werner ;
Mineur, Laurent ;
Molinari, Nicolas ;
Reboul, Francois .
EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2008, 33 (05) :829-836
[60]   A Rare Case of Primary Malignant Pericardial Mesothelioma [J].
Ramachandran, Rajoo ;
Radhan, Prabhu ;
Santosham, Roy ;
Rajendiran, Swaminathan .
JOURNAL OF CLINICAL IMAGING SCIENCE, 2014, 4